Miao; Yu

Patent Applications and Registrations

Patent applications and USPTO patent grants for Miao; Yu.The latest application filed is for "modified axl peptides and their use in inhibition of axl signaling in anti-metastatic therapy".

Company Profile

2.9.20

Miao; Yu - Sunnyvale CA
Miao; Yu - Stanford CA
Miao; Yu - Wuxi CN
Miao; Yu - Corvallis OR US
Miao; Yu - Plano TX

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Modified AXL Peptides and Their Use in Inhibition of AXL Signaling in Anti-Metastatic Therapy App 20220220458 - Giaccia; Amato J. ; et al.	2022-07-14
Modified AXL peptides and their use in inhibition of AXL signaling in anti-metastatic therapy Grant 11,136,563 - Giaccia , et al. October 5, 2	2021-10-05
sPD-1 VARIANT - FC FUSION PROTEINS App 20200181231 - Giaccia; Amato J. ; et al.	2020-06-11
Igbt Short-circuit Detection And Protection Circuit And Igbt-based Controllable Rectifier Circuit App 20190386483 - Miao; Yu ; et al.	2019-12-19
Corona Discharge Reactor And Method For Using App 20180290123 - Jovanovic; Goran Nadezda ; et al.	2018-10-11
Igbt Short-circuit Detection And Protection Circuit And Igbt-based Controllable Rectifier Circuit App 20180287372 - Miao; Yu ; et al.	2018-10-04
Modulation Of Axl Receptor Activity In Combination With Cytoreductive Therapy App 20180140679 - Giaccia; Amato J. ; et al.	2018-05-24
Inhibition Of Axl/gas6 Signaling In The Treatment Of Liver Fibrosis App 20180094034 - O'Connor; Patrick ; et al.	2018-04-05
Modified Axl Peptides And Their Use In Inhibition Of Axl Signaling In Anti-metastatic Therapy App 20180030422 - Giaccia; Amato J. ; et al.	2018-02-01
Inhibition of AXL/GAS6 signaling in the treatment of liver fibrosis Grant 9,879,061 - O'Connor , et al. January 30, 2	2018-01-30
Modified AXL peptides and their use in inhibition of AXL signaling in anti-metastatic therapy Grant 9,822,347 - Giaccia , et al. November 21, 2	2017-11-21
High-affinity Binding To Gas6 App 20160266136 - Cochran; Jennifer R. ; et al.	2016-09-15
Inhibition of AXL Signaling in Anti-Metastatic Therapy App 20160108378 - Giaccia; Amato J. ; et al.	2016-04-21
Inhibition of AXL signaling in anti-metastatic therapy Grant 9,266,947 - Giaccia , et al. February 23, 2	2016-02-23
Modified AXL Peptides and Their Use in Inhibition of AXL Signaling in Anti-Metastatic Therapy App 20150315553 - Giaccia; Amato J. ; et al.	2015-11-05
Inhibition of AXL Signaling in Primary Tumor Therapy App 20150315552 - Giaccia; Amato J. ; et al.	2015-11-05
Inhibition of AXL signaling in anti-metastatic therapy Grant 9,074,192 - Giaccia , et al. July 7, 2	2015-07-07
Inhibition of AXL Signaling in Anti-Metastatic Therapy App 20140065143 - Giaccia; Amato J. ; et al.	2014-03-06
Inhibition of AXL signaling in anti-metastatic therapy Grant 8,618,254 - Giaccia , et al. December 31, 2	2013-12-31
Inhibition of AXL/GAS6 Signaling in the Treatment of Disease App 20130189254 - O'Connor; Patrick ; et al.	2013-07-25
Inhibition of AXL Signaling in Anti-Metastatic Therapy App 20130108644 - Giaccia; Amato J. ; et al.	2013-05-02
Inhibition of AXL Signaling in Anti-Metastatic Therapy App 20130017205 - Giaccia; Amato J. ; et al.	2013-01-17
On-board FIFO memory module for high speed digital sourcing and capture to/from DUT (device under test) using a clock from DUT Grant 7,640,471 - Miao , et al. December 29, 2	2009-12-29
On-board FIFO memory module for high speed digital sourcing and capture to/from DUT (device under test) using a clock from DUT App 20080091993 - Miao; Yu ; et al.	2008-04-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.